Table 4 Adjusted Odds Ratios and 95% Confidence Intervals by Vaccination Trimester
From: Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study
Outcome | Second Trimester | Third Trimester | Unvaccinated |
|---|---|---|---|
Primary Outcomes | |||
Preterm birth | 1.49 (1.11, 2.01) | 0.49 (0.34, 0.71) | referent |
Small for gestational age | 0.73 (0.52, 1.03) | 0.85 (0.64, 1.13) | referent |
Secondary Outcomes | |||
Cesarean delivery | 1.05 (0.85, 1.30) | 0.88 (0.72, 1.07) | referent |
Postpartum hemorrhage (> 500 mL) | 1.11 (0.71, 1.74) | 1.22 (0.83, 1.78) | referent |
Intrauterine fetal demise | 1.12 (0.52, 2.38) | 0.25 (0.08, 0.82) | referent |
5 min Apgar < 7 | referent | ||
Umbilical pH < 7.1 | 1.46 (0.99, 2.14) | 0.88 (0.60, 1.30) | referent |
Hypertensive disorder of pregnancy | 0.71 (0.33, 1.54) | 0.83 (0.45, 1.55) | referent |
Gestational diabetes | 1.21 (0.93, 1.58) | 0.99 (0.77, 1.27) | referent |